Viewing Study NCT04551950


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-03-05 @ 5:41 AM
Study NCT ID: NCT04551950
Status: COMPLETED
Last Update Posted: 2024-03-08
First Post: 2020-09-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)
Sponsor: EMD Serono Research & Development Institute, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced cervical cancer View
None Bintrafusp alfa View
None M7824 View
None INTR@PID View
None Transforming growth factor-beta View
None Programmed death-ligand 1 View